[Malignant ovarian cancer: conservative treatment and quality of life in young patients].
OBJECTIVE
Our aim was to summarise our and foreign experience in the field of conservative treatment in patients with malignant ovarian tumors.


METHODS
We tried to evaluate the 10 years experience of our and foreign practice and expertise in conservative treatment of relatively young patients with ovarian cancer. 22 patients were evaluated--all treated conservatively because of malignant ovarian tumors (early stage I as well as advanced tumor processes--stage II and stage III). All of them were treated conservatively as they signed a consent form beforehand. All of them (22) patient were collected from National Oncological Centre, Gynecology, Sofia; RHW in Sydney as well as from the Obstetrics & Gynecological Hospital-Varna. These patients were treated and followed for 10 years period (all of them were under the age of 40 years old). 18 patients were stage I and 4 in advanced stage.


RESULTS
All these patients were treated by conservative surgery; 6 of them got pregnant, another 6 patients have the chance to get pregnant. The five and ten years survival rate were 85% and 82% respectively in all stages and 97% and 95% for early stages of these ovarian neoplasias.


CONCLUSIONS
Our results are the same as the results obtained from prestigious western clinics.
Ivanov
S
S
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007247:Infertility, Female / Q000517:prevention & control; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D010052:Ovariectomy; D011788:Quality of Life